Search Results - "Rangaratnam, S"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease by Ruttledge, M H, Andermann, A A, Phelan, C M, Claudio, J O, Han, F Y, Chretien, N, Rangaratnam, S, MacCollin, M, Short, P, Parry, D, Michels, V, Riccardi, V M, Weksberg, R, Kitamura, K, Bradburn, J M, Hall, B D, Propping, P, Rouleau, G A

    Published in American journal of human genetics (01-08-1996)
    “…The gene predisposing to neurofibromatosis type 2 (NF2) on human chromosome 22 has revealed a wide variety of different mutations in NF2 individuals. These…”
    Get full text
    Journal Article
  2. 2

    Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas by Ruttledge, Martin H, Sarrazin, Julie, Rangaratnam, Shyam, Phelan, Catherine M, Twist, Elspeth, Merel, Philippe, Delattre, Olivier, Thomas, Gilles, Nordenskjöld, Magnus, Collins, V. Peter, Dumanski, Jan P, Rouleau, Guy A

    Published in Nature genetics (01-02-1994)
    “…Meningiomas are common central nervous system tumours which present usually in the 4th and 5th decades of life. Loss of constitutional heterozygosity on…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene by Watkins, David, Ruttledge, Martin H., Sarrazin, Julie, Rangaratnam, Shyam, Poisson, Michel, Delattre, Jean-Yves, Rouleau, Guy A.

    Published in Cancer genetics and cytogenetics (01-11-1996)
    “…The molecular genetic alterations that underlie development of gliomas, the most common neoplasm of the human central nervous system, include activation of…”
    Get full text
    Journal Article